The 3 Small CRISPR Biotechs That Could Cure 10,000 Diseases Post author:Sam Post published:February 4, 2018 Post category:BioPharma A look at three small biotech companies that appear to be leading the CRISPR race. Source: BioSpace You Might Also Like DelMar Pharma Announces Fiscal Year 2017 Financial Results September 28, 2017 Tiny Corbus Aims to Have Four Drugs in Mid- to Late-Stage Development by Next Year November 20, 2017 Ocular Therapeutix to Slash Jobs After FDA Rejection August 1, 2017
